ArticleEnvironmental toxicology2026
Preclinical Toxicity Screening of Sodium Dodecanoyloxybenzenesulfonate (LOBS) as a New Alternative Biocide Using In Vitro and In Vivo Models.
Article in Environmental toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sodium hypochlorite is a well-established biocide extensively used in both living and industrial environments; however, exposure to it or improper handling can harm the human body and the environment. Thus, safer alternatives to sodium hypochlorite are required. Therefore, the objective of this research was to assess the genotoxicity, cardiotoxicity, 2-week repeated-dose toxicity studies (oral, dermal), and acute irritation/corrosion of sodium dodecanoyloxybenzenesulfonate (LOBS), a new alternative biocide in various biological systems. LOBS did not show genotoxic or cardiotoxic effects in the bacterial reverse mutation test, chromosomal aberration test, or hERG assay. Both males and females showed an increase in U-Na levels (p < 0.01), while an increase in focus/foci, thickness in the stomach, and discoloration was observed in the thymus of males during the 2-week repeated oral-dose toxicity study. In the 2-week repeated dermal-dose toxicity study, no significant adverse effects were observed. While mild erythema and edema were observed in all animals during the acute dermal irritation/corrosion study, all the animals recovered. During the acute eye irritation/corrosion study, all animals showed mild corneal clouding, conjunctival redness, and conjunctival chemosis; however, all animals recovered. Moreover, LOBS was classified into category 3 (mild irritant) and category 2A (irritant) in the acute dermal and eye irritation/corrosion studies. Therefore, LOBS should be further developed as a potential alternative biocide to sodium hypochlorite.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.